This is a firm-fixed price Blanket Purchase Agreement (BPA) call contract awarded by the Defense Health Agency to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for the delivery of reagents and peripheral supplies for in vitro studies, with a potential value of $159,366.48 and a completion date of September 30, 2019. Qiagen has extensive experience providing specialized products and services to support federal agencies' biomedical research,...
This is a Blanket Purchase Agreement (BPA) call order awarded by the Defense Health Agency (DHA) to Qiagen, LLC, a division of Qiagen N.V., for reagents and consumables. The contract has a ceiling value of $180,000.00 and a period of performance through September 30, 2017. This call order is part of a larger BPA vehicle that Qiagen holds with DHA, which has been used to efficiently acquire Qiagen's specialized products and services such as DNA/RNA extraction kits, next-generation sequencing, and...
This federal contract award was issued by the Defense Health Agency (DHA) to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions. The $194,762.36 Blanket Purchase Agreement (BPA) Call contract is for the delivery of reagents and consumables, with a firm fixed price and an ultimate completion date of September 1, 2025. Qiagen, LLC is not a small business set-aside, reflecting the company's ability to compete...
This is a firm fixed-price BPA call contract awarded by the Defense Health Agency (DHA) to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and laboratory equipment. The $156,764.92 ceiling value contract is for the supply of reagents and consumables, with a performance period ending on March 18, 2025. Qiagen, headquartered in Germantown, Maryland, has an extensive history of providing prime and subcontract goods and services to federal agencies like the National...
The Defense Health Agency awarded a $125,000 firm fixed price blanket purchase agreement call contract to Qiagen, LLC for reagents and supplies. Qiagen, LLC is a division of Qiagen N.V., its parent company. The contract has a performance period through February 26, 2021 in Bethesda, Maryland and does not have a set-aside designation. As the Defense Health Agency supports the medical readiness of military forces, this contract will likely provide critical reagents and consumable laboratory...
This is a Firm Fixed Price contract awarded by the Defense Health Agency (DHA), a component of the Department of Defense, to Qiagen, LLC for a reagent kit needed to sequence libraries. The contract has a ceiling value of $22,607.27 and a completion date of September 30, 2024. Qiagen is a division of the international provider Qiagen N.V. and has extensive experience supporting federal agencies' biomedical research, public health, and healthcare programs through past prime and subcontract awards....
This is a firm fixed-price Blanket Purchase Agreement (BPA) call award to Qiagen, LLC, a division of the international provider of sample and assay technologies Qiagen N.V. The $24,990.74 award is for the delivery of Whole Genome Kits to the Defense Health Agency, a component of the Department of Defense. This BPA call is part of a larger indefinite delivery contract vehicle that Qiagen holds to provide specialized products and services to various federal agencies, including the Army, Bureau...
This is a Blanket Purchase Agreement (BPA) call awarded by the Office of Logistics and Acquisition Operations, a civilian agency, to Qiagen, LLC, a division of the international provider of sample and assay technologies Qiagen N.V. The $20,953.54 firm fixed price award is for the delivery of chemicals. The contract has no set-aside designation and a performance period through April 30, 2025. Qiagen has provided a range of products and services, including DNA/RNA extraction kits,...
This federal contract award is for the delivery of controls, reagents, and consumables from Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The $202,026.53 firm-fixed-price delivery order was awarded by the Defense Health Agency (DHA) and is not set aside for any special designations. Qiagen is an experienced federal contractor, holding multiple indefinite delivery vehicles (IDVs) and blanket purchase agreements (BPAs) with agencies such as the Department of...
This is a $10,397.51 firm-fixed-price delivery order contract awarded by the Defense Health Agency to Qiagen, LLC, a division of the international firm Qiagen N.V. The contract is for the provision of medical supplies, with a period of performance through September 30, 2023. Qiagen has provided a range of products and services supporting federal biomedical research, public health, and healthcare programs, including DNA/RNA extraction kits, sequencing equipment, and bioinformatics software. The...